The Republic of Sierra Leone Transitioning As Africa’s First Ever “Smart Country”
Today, Sierra Leone President Dr. Ernest Bai Koroma and RippleNami Inc., a blockchain systems solution provider, announce a nationwide digitization program that will forever change Sierra Leone's global digital standing. By leapfrogging legacy information communication technology (ICT) systems with RippleNami's proprietary technology platform, Sierra Leone is poised to penetrate global markets, obtain economic independence, and elevate the prosperity of its people.
RippleNami architects the blockchain data visualization platform that empowers citizens and organizations across the nation to generate, collect, analyze and transact data while positioning Sierra Leone as Africa’s very first “Smart Country.”
In collaboration with the government of Sierra Leone and Data Edge Revenue, a Freetown systems integration company, RippleNami developed the application software that connects people, organizations and resources to services that create social, civic and economic opportunities far beyond any prior capabilities.
This collaboration’s first phase is a nationwide economic identification service. This program provides the digital credentials and collections systems to increase financial inclusion and to improve access to public and government-provided services. The implementation is underway and will roll out fourth-quarter 2017.
In addressing the UN General Assembly today, Sierra Leone’s Minister of Foreign Affairs, Dr. Samura Kamara, speaking on behalf of President Koroma, said, “Today we announce a quantum leap towards digitizing a national program, empowering Sierra Leone to obtain economic independence and aggressively compete in global markets while elevating the prosperity of its people. For the first time in our nation's proud history, Sierra Leone, in partnership with RippleNami, will deploy the blockchain-data visualization system solution that enables Sierra Leone to generate, own, collect, analyze and transact data on a nationwide scale – making Sierra Leone Africa’s first “Smart Country.”
“For the first time ever, the people and organizations of Sierra Leone can leverage their individual and collective assets to fully participate in and benefit from the global economy,” said Phil Gahn, founder and chief business development officer of RippleNami. “The visionary leadership of President Koroma and the commitment of the people of Sierra Leone serve as a beacon for other West Africa nations to obtain and sustain a brighter future through digitization. Our partnership with Data Edge Revenue, and our experience delivering services on our platform in Sierra Leone, stand to benefit the entire region in unforeseen ways.”
Advancements in blockchain and cloud computing, as well as the country’s broad adoption of mobile lifestyles, enable Sierra Leone to leapfrog legacy ICT systems and make essential services affordable and quickly accessible at scale. “We operate with a clear understanding that data is the new currency in today’s economy,” said Jaye Connolly-LaBelle, president and chief executive officer of RippleNami. “This program cost-effectively positions countries like Sierra Leone to deploy data-driven services that dramatically improve the lives of their citizens and is easily replicable in neighboring countries.”
The visualization capabilities of RippleNami's platform play a central role in resource management and other planning disciplines undertaken by the government and citizens of Sierra Leone. These proprietary capabilities integrate blockchain transactions with other big data sources to help users detect patterns, identify trends and analyze gaps in ways that lead to better decisions in shorter timeframes.
The program also involves a unique service deployment model leading to faster large-scale adoption of the platform enabled services. Sierra Leone government ministries, municipal councils and private businesses in collaboration with RippleNami and Data Edge Revenue are honored to launch and promote these services throughout the country.
About RippleNami, Inc.
RippleNami develops and deploys complete blockchain-based solutions to accelerate mass adoption of digital technologies in any developing country. RippleNami solutions drive new standards for cost-effectiveness and scalability, empowering any nation to transform itself through digitization, and swiftly benefit from a “Smart Country” standing. RippleNami's blockchain data visualization platform integrates diverse data sets from unlimited sources. The platform’s visualization capability paints a multi-dimensional picture of all relevant information to quickly identify trends, patterns and gaps to produce informed decisions faster. RippleNami solutions enable emergent economies to generate process, manage, share and transact information on a national scale – opening up a world of opportunities for economic inclusion for its citizens and independence for the nation. For more information about RippleNami, visit ripplenami.com
About Data Edge Revenue
Based in Freetown, Sierra Leone, Data Edge Revenue is focused on delivering and deploying integrated blockchain technology solutions to help West African countries become fully digitized. The company works directly with government ministries, local businesses and non-governmental organizations to deploy blockchain technology to help them better serve their communities.
About Sierra Leone
The Republic of Sierra Leone is a country in West Africa with a total area of more than 70,000 km (27,000 sq. mi) and a population of more than 7 million people. In the last decade, President Ernest Bai Koroma’s Agenda for Change, followed by his Agenda for Prosperity, the country has made significant economic and infrastructure advancements. By implementing a blockchain information infrastructure, the country takes a dramatic step to becoming an economically independent and prosperous nation and Africa’s first Smart Country .
Julie Matibag, 1-858-775-6378
Media & Press Relations
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Andersen Global Expands Presence in Germany with Addition of Thierhoff Müller & Partner13.12.2017 08:01 | Pressemelding
Andersen Global is proud to announce an expanded presence in Germany as Thierhoff Müller & Partner, a tax and legal firm with offices in Leipzig and Frankfurt, combines its practice with Andersen Tax & Legal in Germany. Through its German member firms, Andersen Tax & Legal and Alegis Steuerberatungsgesellschaft mbH, Andersen Global now has more than 65 professionals focused on providing tax and legal services and business advice across five locations in Germany, including Cologne, Dusseldorf, and Merzig. “Thierhoff Müller is highly regarded in complex restructuring matters. Together with our existing legal and tax practice, we will be able to increase our service offerings for our clients,” said Stefan Kraus, Managing Partner of Andersen Tax & Legal in Germany. “We are dedicated to providing outstanding service and are adding additional competencies in tax and legal such as corporate r
Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs13.12.2017 08:00 | Pressemelding
Aprecia Pharmaceuticals, LLC (“Aprecia”), The 3DP Pharmaceutical Company, and Cycle Pharmaceuticals, Ltd. (“Cycle”) today announced they have signed a partnership agreement to develop and commercialize orphan drugs using three-dimensionally printed (“3DP”) technology. The planned products will deliver quality-of-life improvements versus existing, approved orphan drugs, and will achieve this by utilizing Aprecia’s proprietary 3DP ZipDose® Technology platform. ZipDose® is the only three-dimensional printing technology used in a pharmaceutical drug product approved by the U.S. Food and Drug Administration. Antonio Benedetti, CEO of Cycle commented: “Many rare disease patients do not have a treatment option at all. For those rare diseases where there is an approved pharmaceutical treatment, patients continue to be burdened by sub-optimal drug formulations. Aprecia’s
Group Vivendi Africa Deploys Netcracker OSS to Enhance Service Management as it Expands Across the Continent12.12.2017 16:07 | Pressemelding
Netcracker Technology announced today that its OSS suite was selected and deployed to support the long-term growth strategy of Group Vivendi Africa (GVA). GVA is a newly formed affiliate of the French-based multinational conglomerate Vivendi with the goal to deploy and operate a fiber network across Africa. Netcracker's OSS will be used as a consolidated solution to identify service availability across GVA's operating countries and then fulfill and provision those services to customers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005937/en/ Netcracker's highly productized, out-of-the-box applications enabled the OSS suite to be deployed in seven months, meeting GVA's demand to leverage an integrated service fulfillment and inventory solution that could satisfy its long-term growth expectations, as well as s
Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program12.12.2017 15:23 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today released its latest Scientific Update for Smoke-Free Products, a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes. The latest issue of the Scientific Update can be found at this link. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005891/en/ Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program (Photo: Business Wire) This issue of the Scientific Update provides a closer look at some of the principles and practices on which PMI’s scientific assessment program is built. Director Medical Affairs Dr. Patrick Picavet describes specific examples from PMI’s clinical program that highlight the company’s
Murex to Offer MX.3 Risk, Trading and Post-Trade Solutions on the AWS Cloud12.12.2017 14:00 | Pressemelding
Murex, an industry leader in trading, risk management and processing solutions for capital markets, announced they will run their MX.3 technology platform on Amazon Web Services, Inc. (AWS). With the acceleration of cloud adoption in capital markets, Murex and AWS agreed to collaborate to help clients migrate their Murex application workloads to the AWS Cloud. Murex clients are looking to consolidate more and more of their capital markets activity on the MX.3 platform and this means their need for infrastructure is increasing. New regulatory requirements are also driving financial organizations to use cloud to scale up their computing capacity. Murex is collaborating with AWS to meet the demand from clients to support deployment of the Murex offering on the AWS Cloud. Murex is working on the validation of a range of deployment scenarios, from using AWS Cloud for bursting grid
Darzalex®▼(daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible12.12.2017 13:33 | Pressemelding
Janssen-Cilag International NV (“Janssen”) today announced data from the Phase 3 ALCYONE study, showing Darzalex® (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) significantly improved clinical outcomes, including reducing the risk of disease progression or death by 50 percent, in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (ASCT).1 These data were accepted as a late-breaking abstract (LBA) for presentation at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, today at 7:30 a.m. ET (Abstract #LBA-4).1 Study findings were simultaneously published in the New England Journal of Medicine (NEJM) . 2 Daratumumab is currently indicated for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for